IDO-IN-6
Product Specifications
UNSPSC Description
IDO-IN-6 (NLG-1486) is an indoleamine 2,3-dioxygenase (IDO) inhibitor extracted from patent WO WO2012142237A1, Compound 1486, has an IC50 of <1 μM.
Target Antigen
Indoleamine 2,3-Dioxygenase (IDO)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/IDO-IN-6.html
Purity
99.90
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O[C@H](CC1)CC[C@]1([H])[C@@H](O)C[C@@H]2N3C(C4=C2C(F)=CC=C4)=CN=C3
Molecular Weight
316.37
References & Citations
[1]Mautino, et al. Preparation of fused imidazole derivatives as IDO inhibitors. From PCT Int. Appl. (2012), 20121018.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-18770A/IDO-IN-6-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-18770A/IDO-IN-6-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1402837-76-6
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Polyclonal Antibody to Fibroblast Growth Factor Receptor Substrate 2 (FRS2)
Polyclonal Antibody to Fibroblast Growth Factor Receptor Substrate 2 (FRS2)